What are the annual sales of the antibiotic mupirocin in the US and world wide ?

---

Request for Question Clarification by rainbow-ga on 01 Feb 2006 11:06 PST

Hi horse10,

Please take a look at the following information I was able to compile
regarding the antibiotic ointment, mupirocin, and let me know if this
suffices as an answer to your question:


Associated Press 
Taro Gets FDA OK for Generic Bactroban 
09.23.2005, 01:25 PM 

"Taro Pharmaceutical Industries Ltd. said Friday it received Food and
Drug Administration approval for its generic version of
GlaxoSmithKline PLC's Bactroban ointment, used to treat impetigo.

Taro's Mupirocin ointment is a prescription antibiotic product used
for the topical treatment of impetigo, a bacterial skin infection
characterized by pus-filled blisters that may itch. The condition is
most common in children and is contagious.

Mupirocin ointment products have annual U.S. sales of about $77 million. 

Taro shares rose 42 cents to $26.46 on the Nasdaq, while Glaxo's
American depositary shares were up 82 cents at $50.58 on the New York
Stock Exchange."

Forbes
http://www.forbes.com/home/feeds/ap/2005/09/23/ap2241619.html 



News Release
Taro Receives Approval For Mupirocin Ointment USP, 2% ANDA: Generic
Equivalent to Bactroban Ointment

"HAWTHORNE, N.Y., Sept. 23, 2005 (PRIMEZONE) -- Taro Pharmaceutical
Industries Ltd. (Nasdaq:TARO) reported today that Taro Pharmaceuticals
U.S.A., Inc. has received approval from the U.S. Food and Drug
Administration for its Abbreviated New Drug Application for Mupirocin
Ointment USP, 2% ("mupirocin ointment").

Taro's mupirocin ointment is bioequivalent to GlaxoSmithKline's
Bactroban Ointment(R), 2%. Mupirocin ointment is a prescription
antibiotic product used for the topical treatment of impetigo.
According to industry sources, mupirocin ointment products have annual
U.S. sales of approximately $77.0 million."

Taro Pharmaceutical Industries Ltd.
http://phx.corporate-ir.net/phoenix.zhtml?c=114698&p=irol-newsArticle&ID=760440&highlight=


"Replacement for mupirocin (a topical antibiotic with over $150 M in
annual sales that is only effective against the bacterium implicated
in acne)"
http://www.ceragenix.com/technology_cationic.html


Looking forward to hearing your views.

Best regards,
Rainbow

---

Clarification of Question by horse10-ga on 01 Feb 2006 12:19 PST

Sorry, I should have been more detailed.   I need data I can validate.
  The 77 million number shows up several places.   But look at
http://www.replidyne.com/pdf/JPMorgan.pdf where it says the market for
Bactroban [just one company's name for mupirocin] is $ 250 million.  
So we have a range $ 77m-150m-250 million.

I also wanted to see worldwide data.

Sorry for the inclarity.

Thanks !